van Leeuwen RWF - Search Results

1

Cost-Effective and Sustainable Drug Use in Hospitals: A Systematic and Practice-Based Approach.

Zietse M, van der Zeeuw SL, Gebbink AK, de Vries AC, Crombag MBS, van Leeuwen RWF, Hoedemakers MJ. Zietse M, et al. Among authors: van leeuwen rwf. Appl Health Econ Health Policy. 2025 Mar;23(2):183-195. doi: 10.1007/s40258-024-00937-6. Epub 2024 Dec 19. Appl Health Econ Health Policy. 2025. PMID: 39702592 Free PMC article.

2

Alternative dosing strategies for immune checkpoint inhibitors to improve cost-effectiveness: a special focus on nivolumab and pembrolizumab.

Malmberg R, Zietse M, Dumoulin DW, Hendrikx JJMA, Aerts JGJV, van der Veldt AAM, Koch BCP, Sleijfer S, van Leeuwen RWF. Malmberg R, et al. Among authors: van leeuwen rwf, van der veldt aam. Lancet Oncol. 2022 Dec;23(12):e552-e561. doi: 10.1016/S1470-2045(22)00554-X. Lancet Oncol. 2022. PMID: 36455584 Review.

3

Combatting the rising costs of cancer drugs; interventions from a university hospital's perspective.

Dane A, van Leeuwen R, Hoedemakers M, van der Kuy H, Sleijfer S. Dane A, et al. Front Pharmacol. 2023 Aug 28;14:1264951. doi: 10.3389/fphar.2023.1264951. eCollection 2023. Front Pharmacol. 2023. PMID: 37701038 Free PMC article.

4

Effect of Switching the Histamine-1 Receptor Antagonist Clemastine to Cetirizine in Paclitaxel Premedication Regimens: The H1-Switch Study.

Malmberg R, van Doorn L, Cox JM, Daloul A, Ettafahi H, Oomen-de Hoop E, Zietse M, Bos MEMM, Koch BCP, van Leeuwen RWF. Malmberg R, et al. Among authors: van leeuwen rwf, van doorn l. JCO Oncol Pract. 2024 Sep;20(9):1243-1251. doi: 10.1200/OP.24.00110. Epub 2024 Jun 7. JCO Oncol Pract. 2024. PMID: 38848522

5

Interchangeability of immune checkpoint inhibitors: an urgent need for action.

Zietse M, van Leeuwen RWF, Barjesteh van Waalwijk van Doorn-Khosrovani S, de Boer JE, Dupree R, Mathijssen RHJ, Timmers L. Zietse M, et al. Among authors: van leeuwen rwf. Lancet Oncol. 2024 Nov;25(11):e611-e616. doi: 10.1016/S1470-2045(24)00212-2. Epub 2024 Oct 14. Lancet Oncol. 2024. PMID: 39419062 Review.

6

The administration of immune checkpoint inhibitors via an elastomeric pump versus conventional intravenous infusion: an economic perspective.

Zietse M, Malmberg R, van Leeuwen RWF, Thielen FW, Uyl-de Groot CA. Zietse M, et al. Among authors: van leeuwen rwf. BMC Health Serv Res. 2024 Oct 31;24(1):1322. doi: 10.1186/s12913-024-11719-0. BMC Health Serv Res. 2024. PMID: 39482711 Free PMC article.

7

Environmental Impact Assessment of Intravenous Versus Subcutaneous Monoclonal Antibodies: A Carbon Footprint Analysis.

Zietse M, Kooijman T, Malmberg R, Spierings LEAMM, Jager A, Mathijssen RHJ, van Leeuwen RWF, Thielen FW. Zietse M, et al. Among authors: van leeuwen rwf. JCO Oncol Pract. 2025 Sep;21(9):1287-1295. doi: 10.1200/OP-24-00804. Epub 2025 Feb 21. JCO Oncol Pract. 2025. PMID: 39983075

8

Capacity and cost benefits of subcutaneous versus intravenous pertuzumab/trastuzumab: The EASE-SC study.

Zietse M, Hu J, van Staveren ER, Spierings LEAMM, Jager A, Koch BCP, Mathijssen RHJ, van Leeuwen RWF, Thielen FW. Zietse M, et al. Among authors: van leeuwen rwf. Breast. 2025 Dec;84:104573. doi: 10.1016/j.breast.2025.104573. Epub 2025 Sep 10. Breast. 2025. PMID: 40961902 Free PMC article.

9

Errata: Environmental Impact Assessment of Intravenous Versus Subcutaneous Monoclonal Antibodies: A Carbon Footprint Analysis.

Zietse M, Kooijman T, Malmberg R, Spierings LEAMM, Jager A, Mathijssen RHJ, van Leeuwen RWF, Thielen FW. Zietse M, et al. Among authors: van leeuwen rwf. JCO Oncol Pract. 2025 Jun 4:OP2500482. doi: 10.1200/OP-25-00482. Online ahead of print. JCO Oncol Pract. 2025. PMID: 40466021 No abstract available.

10

Applying a cost-based pricing model for innovative cancer treatments subject to indication expansion: A case study for pembrolizumab and daratumumab.

Heine RJSD, Thielen FW, Mathijssen RHJ, van Leeuwen RWF, Franken MG, Uyl-de Groot CA. Heine RJSD, et al. Among authors: van leeuwen rwf. PLoS One. 2024 Feb 1;19(2):e0293264. doi: 10.1371/journal.pone.0293264. eCollection 2024. PLoS One. 2024. PMID: 38300937 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters